T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab‐based therapy-Reference-Cited by-同舟云学术

T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab‐based therapy

Published:2021-11 Issue:11 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Wang Yujia¹,Xu Lushuang¹,Zhao Weijia¹,Chen Xiaojie²,Wen Lei³,Duan Wenbing³,Yu Xiao‐Juan⁴⁵⁶⁷,De Zhou Fu‐⁴⁵⁶⁷,Liu Yang³,Hao Jie¹,Huang Xiaojun³,Lu Jin³⁸,Ge Qing¹⁹¹⁰^ORCID

Affiliation:

1. Department of Immunology School of Basic Medical Sciences Peking University. NHC Key Laboratory of Medical Immunology (Peking University) Beijing China

2. BasenByte Biotechnology Co., Ltd. Beijing China

3. Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation Peking University People's Hospital & Institute of Hematology Beijing China

4. Renal Division Department of Medicine Institute of Nephrology Peking University First Hospital, & Renal Pathology Center Peking University Beijing China

5. Renal Pathology Center Institute of Nephrology Peking University Beijing China

6. Key Laboratory of Renal Disease Ministry of Health of China Beijing China

7. Key Laboratory of CKD Prevention and Treatment Ministry of Education of China Beijing China

8. Collaborative Innovation Center of Haematology Soochow University Suzhou Jiangsu China

9. Department of Integration of Chinese and Western Medicine School of Basic Medical Sciences Peking University Beijing China

10. National Key Laboratory of Human Factors Engineering China Astronauts Research and Training Center Beijing China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Foundation for Innovative Research Groups of the National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Beijing Municipal Science and Technology Commission

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.582

Reference81 articles.

1. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

2. Future Perspectives

3. Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis;Wang Y;Int J Hematol,2021

4. Tumor cells in light‐chain amyloidosis and myeloma show different transcriptional rewiring of normal plasma cell development [published online ahead of print June 16, 2021.];Alameda D;Blood,2021

5. Systemic immunoglobulin light chain amyloidosis